Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4724 total record number 96 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 422 out of 473
4724 citations found

Development of novel O-polysaccharide based glycoconjugates for immunization against glanders.

Burtnick, MN;Heiss, C;Schuler, AM;Azadi, P;Brett, PJ;

Product: Diphtheria Toxin CRM197, Mutant

  • Glycoconjugate Synthesis:

    … To facilitate conjugation of the OPS antigens to cationized bovine serum albumin (cBSA; Pierce), diphtheria toxin mutant CRM197 (CRM197; List Biological Laboratories, Inc.) … the activated OPS samples were added to small amber vials. …

Product: Botulinum Neurotoxin Type B Light Chain, Recombinant

Product: Tetanus Toxoid from Clostridium tetani

  • Assessing levels of virus production upon antigenic stimulation:

    Peripheral blood mononuclear cells (PBMCs) were cultured at 5106 cells/ml in stimulation medium [RPMI+10% human AB serum+1 g/ml anti-CD28+1 g/ml anti-CD49d+1 M zidovudine (AZT)+1 M lamivudine (3TC)+1 M nevirapine (NVP)] with either 1 g/ml cytochrome c (Austral Biologicals), 1 g/ml HIV-1-p55 (Austral Biologicals), 1 g/ml tetanus toxoid (List Biological Laboratories), …

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

MHC class II and non-MHC class II genes differentially influence humoral immunity to Bacillus anthracis lethal factor and protective antigen

Garman, L;Dumas, EK;Kurella, S;Hunt, JJ;Crowe, SR;Nguyen, ML;Cox, PM;James, JA;Farris, AD;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function

Langer, M;Duggan, ES;Booth, JL;Patel, VI;Zander, RA;Silasi-Mansat, R;Ramani, V;Veres, TZ;Prenzler, F;Sewald, K;Williams, DM;Coggeshall, KM;Awasthi, S;Lupu, F;Burian, D;Ballard, JD;Braun, A;Metcalf, JP;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Materials:

    Highly purified CT was obtained from List Biological Laboratories (Campbell, Ca.). CT was radiolabeled with 125I using the Iodo-gen method as described by Fraker and Speck (1978). …

    Preparation of membranes from post nuclear supernatant of a Vero cell homogenate:

    Vero cells were grown to confluency in 175cm2 culture flasks and maintained in culture for at least 14 days before harvesting. … Cells were then labeled with 125I-CT (106cpm /2 ml 10nM) in the same medium containing 0.01 % bovine serum albumin for 30 min at 4°C to allow binding without endocytosis. …

    Gradient centrifugation:

    Subcellular fractionation was always performed on freshly prepared post nuclear membranes or PNS from cells labeled with 125I-CT. …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Treatments and sensitization with ovomucoid:

    … Days of age were equivalent to experimental days. On days 14, 21, and 35, intraperitoneal (i.p.) injections of 100 g of purified Ovm, prepared in lab (33), adjuvanted with 10 µg of cholera toxin (List Biologicals, CA), were given to all pigs as previously described …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Preparation of fusion proteins and CT-conjugates:

    …  CT-OVA and CTB-OVA conjugates were produced using the crosslinker N-succinimidyl 3(2-pyridyldithio) propionate, (SPDP). CT (LIST Biological Laboratories), rCTB (provided by Dr. J. Holmgren at the Department of Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden) and OVA were coupled to SPDP and conjugated as described before [351]. Concentration of the conjugates, and the OVA content, was determined by ELISA against a standard dilution of CT, CTB and OVA. The molar ratio of OVA to CT or CTB was 4:1.

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae